Skip to search formSkip to main contentSkip to account menu

4-carbamoylimidazolium 5-olate

Known as: 5-hydroxyimidazole 4-carboxamide 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Imidazoles

Narrower (1)

SM 108

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
New AntitumorlmidazoleDerivative , 5-Carbamoyl-1 H-imidazol-4-yI Piperonylate , as an Inhibitorof PurineSynthesisand Its Activation by Adenine Phosphoribosyltransferas &
The mechanism of action of 5-carbamoyl-i H-imidazol-4-yI piperonylate (SL-i 250), which has a broad antitumor spec trum, was… 
2006
2006
Significance of Furine Salvage in Circumventing the Action of Antimetabolites in Rat Hepatoma Cells1
The flux activities of de novo and salvage purine synthesis were compared in rat hepatoma 3924A cells in various growth phases… 
1996
1996
Induction of erythroid differentiation of K562 cells by 4-carbamoylimidazolium 5-olate (SM-108)
1991
1991
Induction of erythroid differentiation of K562 cells by 4-carbamoylimidazolium 5-olate (SM-108).
1988
1988
[Treatment of myelodysplastic syndrome using SM-108 in relation to stem cell kinetics].
Eighteen patients in a high-blast group of myelodysplastic syndrome were treated with low-dose SM-108 (4-carbamoylimidazolium 5… 
1986
1986
Selective reduction of intracellular guanosine 5'-triphosphate pool by 4-carbamoylimidazolium 5-olate in murine tumor cells.
Ehrlich carcinoma and P388 leukemia cells were rendered resistant to 4-carbamoylimidazolium 5-olate (SM-108), and assessments… 
1983
1983
Optimal treatment schedule and antitumor spectrum of 4-carbamoylimidazolium 5-olate (SM-108) in murine tumors.
By designing optimal administration schedules, it was found that 4-carbamoylimidazolium 5-olate (SM-108) showed an excellent… 
1982
1982
New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.
The mechanism of action of 5-carbamoyl-1H-imidazol-4-yl piperonylate (SL-1250), which has a broad antitumor spectrum, was… 
1982
1982
Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
Two new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate (SL-1250) and 4-carbamoylimidazolium 5-olate (SM-108), were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)